Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Hemoglobin; F (fetal), qualitative

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 83033 refers to a laboratory test specifically designed to identify fetal hemoglobin, also known as hemoglobin F (HbF), in various biological samples such as gastric or stool specimens and amniotic fluid. Hemoglobin is a crucial protein found in red blood cells (RBCs) that is responsible for transporting oxygen throughout the body. Fetal hemoglobin differs from adult hemoglobin in that it has a higher affinity for oxygen, which is essential for the developing fetus to efficiently extract oxygen from the maternal blood supply. Hemoglobin F is typically present during fetal development, beginning around 10 weeks of gestation, and continues to be produced for approximately six months after birth. The qualitative test for hemoglobin F is particularly useful in clinical scenarios where there is a need to ascertain the source of gastrointestinal bleeding in infants, distinguishing between maternal and infant sources. Additionally, this qualitative testing may be performed alongside other tests, such as those for alpha-fetoprotein (AFP) and acetylcholinesterase, to further investigate elevated AFP levels in amniotic fluid, thereby providing a comprehensive assessment of fetal health and development.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The qualitative test for fetal hemoglobin (HbF) is indicated in several clinical scenarios, particularly when there is a need to evaluate gastrointestinal bleeding in infants. The following conditions may warrant the performance of this test:

  • Gastrointestinal Bleeding This test helps determine the source of gastrointestinal blood, distinguishing whether it originates from maternal or infant sources.
  • Fetal Development Assessment It is utilized to monitor fetal health during pregnancy, especially in cases where there are concerns about fetal anemia or other hematological conditions.
  • Amniotic Fluid Analysis The test may be performed in conjunction with other tests, such as alpha-fetoprotein (AFP) and acetylcholinesterase, to validate elevated levels of AFP in amniotic fluid.

2. Procedure

The procedure for conducting the qualitative test for fetal hemoglobin involves several key steps, which are outlined below:

  • Sample Collection The first step in the procedure is the collection of appropriate biological samples. This may include gastric or stool specimens from an infant, or amniotic fluid obtained through amniocentesis. Proper collection techniques are essential to ensure sample integrity and accuracy of test results.
  • Laboratory Analysis Once the samples are collected, they are sent to a laboratory where they undergo analysis. The laboratory personnel will utilize specific reagents and techniques to detect the presence of fetal hemoglobin in the samples. This may involve the use of immunoassays or other qualitative testing methods designed to identify HbF.
  • Result Interpretation After the analysis is complete, the laboratory will interpret the results. A positive result indicates the presence of fetal hemoglobin, which may suggest that the gastrointestinal bleeding is of maternal origin if detected in stool or gastric samples. The results will be documented and reported to the requesting physician for further evaluation and management.

3. Post-Procedure

Post-procedure care for the qualitative fetal hemoglobin test primarily involves monitoring the infant for any signs of gastrointestinal bleeding or other complications. If the test is performed on amniotic fluid, the healthcare provider may discuss the implications of the results with the patient, including any necessary follow-up testing or interventions. It is important for healthcare professionals to ensure that parents or guardians are informed about the results and any further steps that may be required based on the findings. Additionally, documentation of the test results and any subsequent actions taken should be maintained in the patient's medical record for continuity of care.

Short Descr HEMOGLOBIN FTL F ASSAY QUAL
Medium Descr HEMOGLOBIN F FETAL QUALITATIVE
Long Descr Hemoglobin; F (fetal), qualitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2023-01-01 Note Short description changed.
2011-01-01 Changed Short description changed.
2001-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"